Article Text

PDF
Farewell to androsterone in atromid

Abstract

ICI have now withdrawn their product Atromid, a mixture of clofibrate and androsterone. As we said two years ago, trials have clearly shown that androsterone in the mixture has no effect on plasma lipids.1 More recent work has shown that androsterone also contributes nothing to the effects on plasma fibrinogen and platelet adhesiveness. Clofibrate alone will continue to be available in Britain under the awkward trade name ‘Atromid-S’.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.